PAI Partners in talks to buy SGD Pharma: Reuters

PAI Partners is in talks to buy SGD Pharma, a French supplier of COVID-19 vaccine vials, from China Jianyin Investment, reported Reuters.

16 June 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles